295 related articles for article (PubMed ID: 17122202)
1. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
Body SC; Mazer CD
Anesth Analg; 2006 Dec; 103(6):1354-9. PubMed ID: 17122202
[No Abstract] [Full Text] [Related]
2. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
Beattie WS; Karkouti K
Anesth Analg; 2006 Dec; 103(6):1360-4. PubMed ID: 17122203
[No Abstract] [Full Text] [Related]
3. Blood-sparing drugs: aprotinin, tranexamic acid, and epsilon-aminocaproic acid.
Royston D
Int Anesthesiol Clin; 1995; 33(1):155-79. PubMed ID: 7543455
[No Abstract] [Full Text] [Related]
4. ε-Aminocaproic acid and clinical value in cardiac anesthesia.
Raghunathan K; Connelly NR; Kanter GJ
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):16-9. PubMed ID: 20870423
[TBL] [Abstract][Full Text] [Related]
5. The post-BART anti-fibrinolytic dilemma?
Beattie WS; Karkouti K
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):3-5. PubMed ID: 21272775
[No Abstract] [Full Text] [Related]
6. Current status of non-transfusional haemostatic agents.
Cattaneo M; Mannucci PM
Haematologica; 1999 Jun; 84 Suppl EHA-4():120-3. PubMed ID: 10907488
[No Abstract] [Full Text] [Related]
7. Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials.
Takagi H; Manabe H; Kawai N; Goto SN; Umemoto T
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):98-101. PubMed ID: 19380335
[TBL] [Abstract][Full Text] [Related]
8. Antifibrinolytics.
Schmarts
Acta Anaesthesiol Belg; 2003; 54(4):319-22. PubMed ID: 14719353
[No Abstract] [Full Text] [Related]
9. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
[TBL] [Abstract][Full Text] [Related]
11. [Commentary on the article of Dennis T. Mangano: Aprotinin and risks in cardiac surgery].
Bizouarn P
Ann Fr Anesth Reanim; 2006 Jul; 25(7):791-5. PubMed ID: 16839738
[No Abstract] [Full Text] [Related]
12. Pharmacologic methods to reduce perioperative bleeding.
Levy JH
Transfusion; 2008 Mar; 48(1 Suppl):31S-38S. PubMed ID: 18302580
[No Abstract] [Full Text] [Related]
13. Aprotinin: 1 year on.
Dietrich W
Curr Opin Anaesthesiol; 2009 Feb; 22(1):121-7. PubMed ID: 19295302
[TBL] [Abstract][Full Text] [Related]
14. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
Laupacis A; Fergusson D
Anesth Analg; 1997 Dec; 85(6):1258-67. PubMed ID: 9390590
[TBL] [Abstract][Full Text] [Related]
15. eComment: A comparison of the safety of aprotinin and tranexamic acid in cardiac surgery.
Koniari I; Apostolakis E; Mandellou M
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):101. PubMed ID: 19546299
[No Abstract] [Full Text] [Related]
16. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery.
Brown JR; Birkmeyer NJ; O'Connor GT
Circulation; 2007 Jun; 115(22):2801-13. PubMed ID: 17533182
[TBL] [Abstract][Full Text] [Related]
17. Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study.
Jakobsen CJ; Søndergaard F; Hjortdal VE; Johnsen SP
Eur J Cardiothorac Surg; 2009 Nov; 36(5):863-8. PubMed ID: 19782573
[TBL] [Abstract][Full Text] [Related]
18. Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials.
Carless PA; Moxey AJ; Stokes BJ; Henry DA
BMC Cardiovasc Disord; 2005 Jul; 5():19. PubMed ID: 15992412
[TBL] [Abstract][Full Text] [Related]
19. Lessons learned in antifibrinolytic therapy: The BART trial.
Murkin JM
Semin Cardiothorac Vasc Anesth; 2009 Jun; 13(2):127-31. PubMed ID: 19622534
[TBL] [Abstract][Full Text] [Related]
20. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
Yasim A; Aşik R; Atahan E
Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
